glp-1 vs metformin Ozempic: What's the Difference? Metformin: Anchoring Potential in GLP-1

Limitations include small cohorts, short follow-up, heterogeneous peptide types and doses, and mixed endpoints

Less common: joint stiffness (usually resolves), carpal tunnel symptoms at higher doses, mild fasting glucose elevation

Natural growth hormone output declines steadily with age, and CJC-1295 and Ipamorelin take a different path than synthetic GH: rather than replacing the hormone, they signal your own pituitary to release more of it, preserving the body's feedback-controlled, pulsatile rhythm

Median age at diagnosis was nearly identical between patients with and without recent hormonal birth control use when controlling for birth year, suggesting no meaningful difference in diagnosis timing between the two groups